Status:
COMPLETED
Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)
Lead Sponsor:
Carmen Hidalgo Tenorio
Collaborating Sponsors:
Gilead Sciences
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The goal of this study is to analyze in treatment-naïve HIV patients the antiviral activity, using a test and treat strategy, in real life of BIC/FTC/TAF. Secondary, this study aims to evaluate outcom...
Eligibility Criteria
Inclusion
- HIV-1 infected adults (\>17 y.o.)
- Antiretroviral-naïve.
- Be able to comply with protocol requirements and instructions.
- Subject or the subject's representative capable of giving signed informed consent
Exclusion
- Women who are breastfeeding or plan to become pregnant during the study.
- Patients who in the investigator's judgment, poses a significant drop out risk or life expectancy inferior to study ending.
- Patients with anticipated need to change the ART before study ending.
Key Trial Info
Start Date :
October 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
208 Patients enrolled
Trial Details
Trial ID
NCT06177574
Start Date
October 27 2020
End Date
October 30 2023
Last Update
December 20 2023
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen de Las Nieves
Granada, Andalusia, Spain, 18008
2
H JEREZ
Jerez de la Frontera, Cádiz, Spain
3
Hospital Universitario Torrecárdenas
Almería, Spain
4
Hospital Universitario Puerto Real, INIBICA,
Cadiz, Spain